Health Ministry Removes Pack Size Provisions for Chest Pain Formulations

The Ministry of Health and Family Welfare has recently announced an amendment to the Drugs Rules, 1945, regarding the pack size norms of glyceryl trinitrate and isosorbide dinitrate formulations, which are used to treat chest pain.

AstraZeneca To Acquire Fusion For USD 2 Billion

AstraZeneca will acquire drug developer Fusion Pharmaceuticals Inc (FUSN.O),for $2 billion in real money as the Old Swedish drugmaker bets on on next-generation cancer treatments. The agreement gives AstraZeneca traction in the...

Ziqitza Healthcare Donates 100 Wheelchairs for patient care

A charitable initiative has been launched to improve the quality of life for individuals with mobility challenges in government hospitals across 23 districts.

SteinCares to Distribute Bio-Thera Solutions' Biosimilars in LATAM

Bio-Thera Solutions, a biopharmaceutical company focused on developing innovative therapies and biosimilars, has announced a new licensing agreement with SteinCares, Latin America's leading specialty healthcare company.

Pharma Failures & IT Raids Linked to Electoral Bonds

According to the data released by the Election Commission, almost thirty-five pharmaceutical companies in India contributed Rs 1,000 crore to political parties through electoral bonds

Sun Pharmaceuticals' Winlevi Granted Approval for Distribution in Australia

Sun Pharmaceutical Industries Limited has recently announced that the Australian Therapeutic Goods Administration (TGA) has granted regulatory approval for Winlevi, a clascoterone cream.

Univ of Calgary Joins Phase II LSALT Trial for Cardiac Surgery Kidney Injury

Arch Biopartners Inc, a late-stage clinical trial company focused on preventing inflammation and acute organ injury

Indian Pharma Embraces UCPMP Guidelines for Ethical Marketing

The Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024 guidelines have been recently released, and the Indian pharmaceutical sector sees it as a practical approach to promoting ethical marketing practices in the country.

FDA Approves Rezdiffra for Noncirrhotic NASH with Liver Fibrosis

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company specializing in developing novel therapeutics for NASH, has announced that the US Food and Drug Administration (FDA) has granted accelerated approval for Rezdiffra

Government Initiatives: Enhancing Healthcare Access for the Elderly people

Forty-nine district hospitals have established geriatric wards in the past three months to cater to patients requiring specialized care. These hospitals have also introduced geriatric clinics for elderly patients seeking OPD services.

© 2025 India Pharma Outlook. All Rights Reserved.